Category:NMPA approved in 2021

Pages in category "NMPA approved in 2021"

The following 5 pages are in this category, out of 5 total.

D

Donafenib (Zepsun)

F

Furmonertinib (Ivesa)

O

Olverembatinib (HQP-1351)

P

Penpulimab (Anniko)

Z

Zimberelimab (Yu Duo)

Retrieved from "https://hemonc.org/w/index.php?title=Category:NMPA_approved_in_2021&oldid=74548"